T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Analog Devices
ADI
$187B
| $722M | 0.09% |
4,943,607
+3,893,057
| +371% | +$613M |
|
227
Verizon
VZ
$198B
| $722M | 0.09% |
14,217,516
+3,870,751
| +37% | +$196M |
|
228
Generac Holdings
GNRC
$13.1B
| $715M | 0.09% |
3,393,799
+185,898
| +6% | +$45.7M |
|
229
Acadia Healthcare
ACHC
$2.89B
| $707M | 0.09% |
10,450,502
-148,251
| -1% | -$10.3M |
|
230
Yum China
YUMC
$16.3B
| $699M | 0.09% |
14,413,586
-1,032,613
| -7% | -$43.5M |
|
231
PACCAR
PCAR
$68.2B
| $695M | 0.09% |
12,658,742
-789,184
| -6% | -$44.4M |
|
232
Expedia Group
EXPE
$38.8B
| $682M | 0.09% |
7,192,939
-1,355,199
| -16% | -$192M |
|
233
SiteOne Landscape Supply
SITE
$4.23B
| $682M | 0.09% |
5,736,347
+1,120,359
| +24% | +$150M |
|
234
Eaton
ETN
$176B
| $678M | 0.09% |
5,383,123
+4,158,351
| +340% | +$582M |
|
235
Rayonier
RYN
$6.53B
| $670M | 0.08% |
19,752,490
+802,718
| +4% | +$29.4M |
|
236
Tradeweb Markets
TW
$22B
| $668M | 0.08% |
9,794,159
-1,326,824
| -12% | -$96.4M |
|
237
Saia
SAIA
$10B
| $658M | 0.08% |
3,500,405
+2,140,625
| +157% | +$430M |
|
238
GSK
GSK
$101B
| $646M | 0.08% |
11,874,974
-274,928
| -2% | -$15.2M |
|
239
Ultragenyx Pharmaceutical
RARE
$2.64B
| $643M | 0.08% |
10,780,156
-1,104,630
| -9% | -$68M |
|
240
SentinelOne
S
$7.78B
| $632M | 0.08% |
27,110,040
+1,751,920
| +7% | +$49.2M |
|
241
Corning
GLW
$142B
| $630M | 0.08% |
20,008,558
+5,451,525
| +37% | +$188M |
|
242
Domino's
DPZ
$11.5B
| $622M | 0.08% |
1,595,858
-12,996
| -0.8% | -$4.81M |
|
243
Align Technology
ALGN
$12.3B
| $621M | 0.08% |
2,623,458
+113,277
| +5% | +$34.8M |
|
244
Cardinal Health
CAH
$54B
| $619M | 0.08% |
11,843,165
-3,055,818
| -21% | -$174M |
|
245
Northrop Grumman
NOC
$81.6B
| $618M | 0.08% |
1,290,934
+567,520
| +78% | +$261M |
|
246
Martin Marietta Materials
MLM
$32.8B
| $617M | 0.08% |
2,063,464
-322,330
| -14% | -$110M |
|
247
Boeing
BA
$181B
| $616M | 0.08% |
4,505,452
+40,474
| +0.9% | +$5.97M |
|
|
SWAV
248
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $615M | 0.08% |
3,214,678
+627,712
| +24% | +$111M |
|
249
Zoom
ZM
$30.9B
| $614M | 0.08% |
5,687,769
-4,130,015
| -42% | -$436M |
|
250
Broadridge
BR
$19.2B
| $613M | 0.08% |
4,301,103
+104,464
| +2% | +$15.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.